Almag

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Almag

What is Almag?

Almag is a pharmaceutical preparation used to manage symptoms related to gastric acidity. It belongs to a class of medications known as antacids. The primary therapeutic goal of this medication is to neutralize the hydrochloric acid present in the stomach, which helps alleviate discomfort associated with various gastrointestinal conditions.

Composition and Mechanism

The formulation typically consists of a combination of magnesium and aluminum compounds. These components work through a chemical neutralization process. When ingested, the alkaline substances in the medication react with the acidic gastric juice, increasing the pH level within the stomach. This reduction in acidity helps to protect the gastric mucosa and provides relief from the burning sensation often experienced in the esophagus and upper abdomen.

Primary Uses

Almag is commonly utilized for the symptomatic relief of conditions characterized by hyperacidity. These may include:

  • Heartburn: A burning sensation in the chest or throat caused by acid reflux.
  • Acid Indigestion: General discomfort or pain in the upper digestive tract.
  • Gastritis: Inflammation of the stomach lining where acid reduction is beneficial for symptom management.
  • Peptic Ulcers: Used as an adjunctive measure to reduce irritation of the ulcerated tissue by gastric acid.

Pharmacological Properties

Unlike systemic medications that are absorbed into the bloodstream to produce an effect, Almag acts locally within the digestive tract. By neutralizing existing acid rather than preventing its production at the source, it generally provides rapid, though temporary, relief. The inclusion of both aluminum and magnesium is often intended to balance the effects on bowel motility, as aluminum-only products can be constipating while magnesium-only products may have a laxative effect.

Regulatory References

  1. Aluminum Hydroxide and Magnesium Hydroxide: MedlinePlus Drug Information

What side effects are possible with Almag?

Possible Side Effects and Safety Information

The official safety profile for Almag, an antacid and anti-flatulent containing aluminum and magnesium salts, addresses two main types of adverse reactions documented in regulatory sources: common gastrointestinal effects and rare, systemic risks. The most common adverse reactions listed in official documents are linked to the drug’s components and affect the Gastrointestinal disorders system, often including diarrhea (associated with magnesium salts) and constipation (associated with aluminum salts), as well as general nausea.

Less frequently, official labeling documents risks to the Metabolism and Nutrition disorders system. These systemic adverse reactions are generally rare and include the potential for Hypophosphatemia and accumulation of metallic ions. These risks are explicitly associated with prolonged use or excessive dosing, differentiating them from acute side effects. The most critical safety consideration is the increased risk of severe adverse reactions, such as Hypermagnesemia and aluminum accumulation/toxicity, in patients with renal impairment or severe renal failure. Government labeling states that the drug is often restricted or requires strict supervision in these specific populations due to the impaired ability to excrete the active metal ions. Furthermore, a high-level safety limitation noted in official prescribing information is the potential for antacids to interfere with the absorption of other orally administered medications.

Overdose and Emergency Response

Overdose and when to seek help

This section describes the officially documented manifestations and required emergency actions for an overdose of Almag, based strictly on government regulatory labeling for antacid combinations.


Documented Overdose Presentations

Overdose, particularly following excessive absorption or in patients with impaired renal function, may lead to systemic toxicity, notably Hypermagnesemia and Hypophosphatemia. Officially documented manifestations include severe hypotension, profound muscle weakness, and the loss of deep tendon reflexes. Potential severe outcomes listed in regulatory documents include cardiac arrhythmias, respiratory depression, and coma.


Regulator-Mandated Emergency Actions

Seek immediate medical attention following any suspected overdose. Contact emergency services is required if severe or life-threatening symptoms, such as cardiorespiratory changes, occur. Treatment is supportive, as no specific antidote is known. The official procedural steps described in regulatory information involve continuous hospital monitoring, including ECG monitoring and assessment of serum electrolyte levels (Magnesium and Phosphate).


Population-Specific Risk

Patients with impaired renal function are explicitly noted in regulatory sources as having a significantly increased risk of severe systemic toxicity due to reduced clearance of the active Aluminum and Magnesium salts.

Therapeutic Uses of Almag

Quick Facts: Almag Therapeutic Uses

  • Target Symptoms: Supports the management of symptoms related to excess stomach acid.
  • Primary Uses: Used for the temporary relief of heartburn, acid indigestion, and sour stomach.
  • Related Conditions: May be administered for symptom management associated with gastritis and peptic ulcer.

Almag is a medication utilized for the relief of temporary symptoms related to the presence of excess stomach acid. It is an established option for managing common discomforts such as occasional heartburn, acid indigestion, and sour stomach.

The medication is frequently incorporated into the treatment regimen for individuals managing conditions that involve hyperacidity, including peptic ulcer and inflammation of the stomach lining (gastritis). It is important to utilize this medication only as directed on the product labeling or by a healthcare professional.

Almag, which often contains active ingredients like aluminum hydroxide and magnesium hydroxide, functions to neutralize stomach acid, which can help support the relief of discomfort.

Regulatory References

  1. [https://medlineplus.gov/druginfo/meds/a601013.html

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

Almag, a combination antacid, is approved for use in adults and adolescents over 12 years old under standard labeled conditions. Eligibility is determined by several critical medical factors and is strictly defined by regulatory documents.

Absolute Contraindications (Must Not Use)

Use is contraindicated in patients with a known hypersensitivity to any component of the formulation. The medicine must not be used by individuals diagnosed with severe renal failure or advanced kidney disease due to the risk of aluminum and magnesium accumulation. Other absolute exclusions include hypophosphataemia (low phosphate levels), intestinal obstruction or ileus, and in patients who are severely debilitated.

Restricted or Conditional Use

Specific populations require caution or limited use. Patients with non-severe renal impairment must strictly avoid prolonged use. Children under 12 years should consult a physician before use, as the product is not recommended for this age group in some official labeling. During pregnancy and lactation, use is generally advised only if the potential benefits outweigh the potential risks and requires asking a healthcare professional.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Almag, as an aluminum- and magnesium-containing antacid, has an established interaction profile focused on altering the absorption of other orally administered medicines.

Key Interaction Categories

Official documents highlight interactions based on two primary mechanisms: reduced gastrointestinal absorption via binding or chelation and increased gastric pH.


Interaction-Related Constraints and Requirements

Regulatory information mandates specific constraints when Almag is taken with other products, mainly revolving around timing-based separation and specific contraindications in at-risk populations.

  • Timing Separation: The absorption of many oral drugs is significantly reduced when taken simultaneously with Almag. Therefore, the administration of Almag must be separated by specific time intervals—often two, four, or six hours—from medicines such as iron salts, bisphosphonates (like alendronate), certain antibiotics (e.g., ciprofloxacin, doxycycline), and specific HIV or Hepatitis C antivirals (e.g., atazanavir, dolutegravir, velpatasvir). The exact required time separation varies by the specific interacting medicine.

  • Citrates and Renal Impairment: The co-administration of Almag with citrate-containing products (including effervescent drugs and some fruit juices) is restricted in patients with renal impairment or those on hemodialysis. Citrates enhance the absorption of aluminum, which can lead to dangerously high systemic aluminum levels and potential toxicity in patients with compromised kidney function. This combination must be avoided entirely in this population.

  • Enteral Nutrition: Almag should not be administered immediately before, during, or after high-protein liquid formulations or continuous enteral tube feeds due to the risk of chemical precipitation and tube blockage.

Mechanism of Action

Almagate, the active ingredient, is an orally administered aluminum-magnesium salt that targets the gastric lumen within the gastrointestinal tract. Its primary interaction is as a chemical neutralizer of hydrochloric acid ( HCl).

Upon contact with gastric secretions, the hydroxide and carbonate components of Almagate undergo a rapid acid-base reaction with the hydrogen ions ( H^+) of hydrochloric acid, producing water ( H2 O) and soluble aluminum and magnesium salts ( AlCl3 and MgCl2).

The immediate molecular consequence is the consumption of free H^+ ions, which elevates the intraluminal pH. This pH increase in the stomach has a downstream effect on the enzyme pepsin, a protease that requires an acidic environment to maintain its active conformation. The elevated pH causes the inactivation of pepsin by shifting the luminal environment above its optimal pH range, thereby inhibiting its proteolytic activity. The overall system-level physiological consequence of this neutralization is a modulation of gastric acidity and protease activity, occurring locally within the digestive system.

Dosage and Administration Information

Official Administration Guidelines

Almag is structured for oral administration only and is available in formats including an oral suspension and a chewable tablet.

Standardized dosing for individuals aged 12 years and older generally specifies 10 mL to 20 mL of the standard strength suspension or 2 to 4 chewable tablets per administration. This regimen is typically scheduled up to four times a day, with doses commonly timed to occur between meals and at bedtime.

Specific administration techniques are required for proper use. The oral suspension must be shaken well prior to accurate measurement with an appropriate dosing device, while the chewable tablet must be chewed thoroughly and is not to be swallowed whole. A critical constraint is the duration of use; the medicine's maximum dosage should not be used continuously for more than two weeks without consulting a healthcare professional.

Regarding age-group rules, individuals under 12 years of age are instructed to seek physician consultation for appropriate dosing. Similarly, patients with certain health conditions, such as kidney impairment, are directed to consult a physician prior to initiating use. These instructions define the standardized procedural limits for utilizing the combination medicine.

Recent Clinical Evidence

Research evidence / Overview of Studies for Almag


Evidence for Use in Acute High Acidity Symptoms

The research base for antacids, including the salts found in Almag, includes evidence that has explored their chemical action. Researchers have often focused on short-term Randomized Controlled Trials (RCTs) to assess these components. These studies usually involve adult populations experiencing conditions characterized by fluctuating or episodic manifestations. The primary outcomes research examined relate to outcomes related to systemic or functional imbalance, such as how quickly and how much the stomach acid environment changes.

Trials was studied for how long it takes a person to report a feeling of relief after using an antacid. Other research has explored the immediate changes measured in gastric fluid, which are outcomes monitoring physiological strain or stress. The data show patterns related to the capability of these salts to quickly raise the pH of stomach contents. The evidence on chemical action is consistently reported in research literature, and findings indicate patterns related to the chemical action of antacid preparations.

Evidence for Gas and Bloating Discomfort

Evidence for the anti-flatulent component, Simethicone, which is combined with the antacids, research examined its ability to manage outcomes related to physical discomfort such as bloating and pressure. This component was evaluated in short-term RCTs, systematic reviews, and meta-analyses, typically involving adults presenting with symptoms like conditions characterized by fluctuating or episodic manifestations such as functional dyspepsia.

Evidence for the anti-flatulent component research describes its physical ability to reduce surface tension in laboratory settings. Trials monitored short-term changes measured during the study period in symptom scores, which contributes to the broader evidence landscape.

Focus on Systemic Exposure and Chemical Action

Pharmacokinetic (PK) pilot studies was observed in small groups of healthy adult volunteers to measure the systemic availability of the active ions. The research data show patterns related to very low systemic absorption. These studies consistently reported that the measured plasma concentrations of Aluminum and Magnesium ions remained at or near the analytical detection limits in the blood samples collected, supporting the classification of the antacid components as generally non-systemic.

Areas of Research Uncertainty and Study Gaps

Follow-up durations were limited in most definitive antacid trials. Long-term effects are not fully established and there is limited information for long-term outcomes regarding the duration of observed changes over many months or years. Data for certain groups remain insufficient, particularly for pediatric and pregnant populations, and information for this group remains insufficient to fully characterize ion exposure and short-term changes in older adults.

Frequently Asked Questions (FAQ)

Common questions about Almag (FAQ)


Q: How long does it usually take to feel the effects of Almag?

A: Almag is described in official information as providing rapid, local action to neutralize existing stomach acid. This chemical action of acid neutralization is the basis for the temporary relief experienced with the product.


Q: Can Almag be used during pregnancy or while breastfeeding?

A: Regulatory labeling states that using Almag during pregnancy is advised only if a healthcare professional determines that the potential benefits outweigh the potential risks. For breastfeeding, some official resources indicate the components are generally not expected to cause harm, though consulting a healthcare professional is necessary before making a decision.


Q: Does Almag cause drowsiness or affect driving?

A: Common drowsiness is generally not listed among the most frequently reported side effects in official product documents. However, systemic effects like drowsiness and confusion are rare, serious effects noted in labeling, mainly associated with use in patients with compromised kidney function.


Q: Is Almag addictive?

A: Almag is an Over-The-Counter (OTC) drug classified as an antacid and anti-flatulent. Official drug classifications do not identify antacids or the anti-flatulent component as having a risk of abuse or addiction.


Q: Can Almag be crushed or opened for easier swallowing?

A: The official administration instructions require the chewable tablet form to be thoroughly chewed before swallowing, and the oral suspension must be shaken well before use. These instructions define the required administration technique for each form, and they should be followed.


Q: Are there any specific lifestyle changes recommended when starting Almag?

A: Some official patient education materials advise that managing factors like stress, stopping smoking, limiting alcohol, and making dietary adjustments may support the effectiveness of the medication. Dosing instructions in official documents also mention the timing of administration, such as taking the product between meals or at bedtime.


Q: Is Almag the same type of medicine as [Common similar drug]?

A: Almag is defined by its composition: it is a Fixed-Dose Combination (FDC) drug containing both acid-neutralizing salts (antacids) and Simethicone, an anti-flatulent. This specific two-in-one preparation distinguishes it from products that contain only a single antacid salt or a single anti-gas agent.


Q: What happens if a dose of Almag is missed?

A: Official patient instructions suggest that if a dose is missed when following a regular schedule, it is advised that the missed dose be skipped entirely if it is nearly time for the next dose. The patient should not take a double dose.


Q: Is Almag a long-term treatment or just for short periods?

A: Official drug labeling warns against using the maximum dosage continuously for more than two weeks, indicating its intent for short-term, temporary relief. The labeling specifies limits on duration, and any continuous use beyond the stated time should be done only as authorized by a physician.


Q: Why do some people say Almag didn't work for them?

A: Official information describes Almag as having a rapid, local action that neutralizes acid already present in the stomach. Its action is limited to neutralizing existing acid and does not prevent the underlying conditions that cause acidity.


Q: How is Almag different from other drugs used for the same purpose?

A: Almag is a combination product that addresses two issues simultaneously: high acidity and gas/bloating. It is different from other single-component products because it combines multiple antacid salts with Simethicone, an anti-flatulent, to offer a balanced and multi-faceted effect.


Q: Do I need a prescription from a doctor to get Almag?

A: According to its official labeling status, Almag is classified as an Over-The-Counter (OTC) medicine, meaning it is available for purchase without requiring a prescription from a doctor.


Q: Can I stop taking Almag suddenly?

A: Because Almag is a locally acting antacid that is not significantly absorbed into the bloodstream, it provides temporary relief for acute symptoms. Consistent with this non-systemic action, regulatory documents do not list risks of withdrawal symptoms upon discontinuing the use of Almag.


Q: What if I take Almag too close to another medication?

A: Taking Almag too close to other oral medications may significantly reduce their absorption into the body. Official labeling mandates a specific time separation between Almag and certain interacting drugs to help minimize the potential for Almag to interfere with the other drug’s absorption.


Q: Do studies suggest Almag is effective for things other than its main use?

A: Official research is focused on the approved uses of Almag for acid symptoms and gas/bloating discomfort. Regulatory documentation does not report findings for other non-labeled conditions.


Q: Is there any risk of withdrawal symptoms when stopping Almag?

A: Due to its mechanism of action as a non-systemic, locally acting product, regulatory documents do not list withdrawal symptoms upon cessation of Almag use. Pharmacokinetic studies show very low systemic absorption of the active ions.


Q: Does Almag need to be taken with food?

A: The administration guidelines in the official procedural framework specify that doses of Almag are commonly timed to occur between meals and at bedtime (or sometimes after meals and at bedtime), as needed for symptom relief.


Q: How long does Almag stay in my system after I stop taking it?

A: Pharmacokinetic studies classify the antacid components as generally non-systemic. Official studies consistently report that measured plasma concentrations of the active ions remain at or near analytical detection limits, indicating very low systemic exposure.


Q: What is the risk of overdose with Almag?

A: Exceeding the maximum recommended dosage limits increases the risk for rare but serious adverse effects. Regulatory warnings focus on the potential for high magnesium levels (Hypermagnesemia) and aluminum accumulation, particularly for individuals with pre-existing renal impairment.


Q: How frequently should I follow up with my doctor while using Almag?

A: The product labeling specifies that if symptoms persist for a period of two weeks or longer, use of the product should cease, and evaluation by a healthcare professional is then required.


Q: Is it okay to drink alcohol while using Almag?

A: Official patient information directs patients with a history of frequent or heavy alcohol use to seek consultation from a healthcare professional prior to initiating use of this product.


Q: Is there a generic version of Almag available?

A: Almag is a brand name for a combination of active ingredients (aluminum hydroxide, magnesium hydroxide, and simethicone). Generic products containing the same combination of active ingredients are available from various manufacturers in the market.

How should Almag be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions necessary to preserve the stability and safety of Almag. This medication must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F).

The product must be protected from freezing. To maintain integrity, the container should be kept tightly closed, and the oral suspension form must be shaken well before using.


Safety and Disposal

All labeling mandates the product be stored out of reach of children. Disposal of any unused or expired Almag must be conducted in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Almag found in:

A-Z Index: